Literature DB >> 8620038

Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.

T Xia1, K Akers, A Z Eisen, J L Seltzer.   

Abstract

The gelatinases (type IV collagenases) are members of the matrix metalloproteinase family that not only have a high degree of structural homology but are known to be nearly identical in their digestion profile against macromolecular substrates. We have shown previously that the preferred cleavage sites in the hydrolysis of type I gelatin, catalyzed by gelatinase A (72 kDa type IV collagenase), are bracketed by hydroxyproline in the P5 and P5' positions. In this report, a kinetic investigation using a series of collagenous dodecylpeptides in which the P5 and P5' hydroxyprolines were systematically varied and used as substrates for recombinant human gelatinase A, we show that replacement with either proline or alanine always resulted in increased Km. In contrast, substitution of the hydroxylated amino acids tyrosine and serine at P5 and P5' reduced the Km significantly, indicating that the hydroxyl moiety of the hydroxyproline is the functional group responsible for favorable enzyme-substrate affinity. This was shown by the kcat/Km ratio, which was doubled by the substitution of serine in that site. Cleavage of the same series of dodecylpeptides by recombinant human gelatinase B (92 kDa type IV collagenase) showed a very different kinetic profile for which no patterns were discernible. In subsequent comparisons of the two enzymes, it was found that gelatinase B cleaved the thiopeptolide substrate AcProLeuGly-S-LeuGly-OC2H5 at double the velocity of gelatinase A. In contrast, gelatinase A digested type I gelatin about 2.5-times faster than gelatinase B. SDS-PAGE analysis of gelatin cleavage products showed different patterns of product peptides for each enzyme. Further comparisons of the proteinases using synthetic peptide substrates with variations in size and in substituents at the P2' site again showed marked kinetic differences. Although these two matrix metalloproteinases seem similar in that they are both gelatinolytic and can degrade a nearly identical battery of macromolecular matrix components including type IV collagen, it is clear from these results that they are very different enzymatically. Since the regulatory portions of gelatinases A and B differ markedly, it has been assumed that the enzymes serve the same function, but respond to different stimuli. The differences in substrate specificity described herein suggest that their proposed physiological roles may require reevaluation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620038     DOI: 10.1016/0167-4838(95)00259-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Using fluorogenic peptide substrates to assay matrix metalloproteinases.

Authors:  G B Fields
Journal:  Methods Mol Biol       Date:  2001

2.  Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; John B Willett
Journal:  Hum Pathol       Date:  2011-01-15       Impact factor: 3.466

3.  In Silico Tissue Engineering: A Coupled Agent-Based Finite Element Approach.

Authors:  Maziyar Keshavarzian; Clark A Meyer; Heather N Hayenga
Journal:  Tissue Eng Part C Methods       Date:  2019-09-20       Impact factor: 3.056

4.  Expression of matrix metalloproteinase-2, tissue inhibitors of metalloproteinase-1, -3 at the implantation site of rhesus monkey during the early stage of pregnancy.

Authors:  F Gao; X L Chen; P Wei; H J Gao; Y X Liu
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

5.  Mechanobiological model of arterial growth and remodeling.

Authors:  Maziyar Keshavarzian; Clark A Meyer; Heather N Hayenga
Journal:  Biomech Model Mechanobiol       Date:  2017-08-19

6.  Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.

Authors:  Samantha J Hauff; Sharat C Raju; Ryan K Orosco; Andrew M Gross; Julio A Diaz-Perez; Elamprakash Savariar; Nadia Nashi; Jonathan Hasselman; Michael Whitney; Jeffrey N Myers; Scott M Lippman; Roger Y Tsien; Trey Ideker; Quyen T Nguyen
Journal:  Otolaryngol Head Neck Surg       Date:  2014-08-04       Impact factor: 3.497

7.  Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice.

Authors:  Anita C Thomas; Andrew C Newby
Journal:  J Vasc Res       Date:  2009-12-16       Impact factor: 1.934

8.  Length-dependent proteolytic cleavage of short oligopeptides catalyzed by matrix metalloprotease-9.

Authors:  Yibing Huang; Junfeng Shi; Dan Yuan; Ning Zhou; Bing Xu
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

Review 9.  Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences.

Authors:  Rogelio Zamilpa; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2009-06-25       Impact factor: 5.000

10.  Active MMP-2 effectively identifies the presence of colorectal cancer.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; Veronica Klepeis; John B Willett
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.